Published in Blood on December 29, 2009
Natural History Study of GATA2 Deficiency and Related Disorders | NCT01905826
Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity (2013) 5.47
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood (2011) 4.21
IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med (2011) 3.29
Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol (2010) 3.27
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood (2011) 3.16
The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med (2011) 2.96
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood (2013) 2.82
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood (2013) 1.93
Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica (2011) 1.89
Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol (2014) 1.81
Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood (2011) 1.76
Natural killer cell deficiency. J Allergy Clin Immunol (2013) 1.74
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med (2015) 1.55
A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med (2015) 1.50
Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature. J Hematol Oncol (2014) 1.49
Myeloid Growth Factors Promote Resistance to Mycobacterial Infection by Curtailing Granuloma Necrosis through Macrophage Replenishment. Cell Host Microbe (2015) 1.47
Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest (2012) 1.47
GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood (2013) 1.44
T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung. Blood (2014) 1.39
Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog (2014) 1.39
Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res (2012) 1.38
The evolution of cellular deficiency in GATA2 mutation. Blood (2013) 1.36
Human dendritic cell deficiency: the missing ID? Nat Rev Immunol (2011) 1.32
Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica (2012) 1.31
Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev (2015) 1.29
Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica (2013) 1.17
GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia. Eur J Pediatr (2012) 1.17
Human dendritic cell functional specialization in steady-state and inflammation. Front Immunol (2014) 1.16
Toll-like receptor alterations in myelodysplastic syndrome. Leukemia (2013) 1.16
MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis (2013) 1.08
Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol (2012) 1.06
New insights into innate immune control of systemic candidiasis. Med Mycol (2014) 1.05
Genetic Susceptibility to Fungal Infections in Humans. Curr Fungal Infect Rep (2011) 1.04
Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol (2015) 1.04
The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol (2013) 1.02
Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr (2013) 1.01
GATA2 mutations lead to MDS and AML. Nat Genet (2011) 0.99
Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome. Haematologica (2011) 0.98
Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk Lymphoma (2015) 0.98
GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood (2014) 0.95
Severe viral infections and primary immunodeficiencies. Clin Infect Dis (2011) 0.94
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biol Blood Marrow Transplant (2014) 0.92
Macrophages: gatekeepers of tissue integrity. Cancer Immunol Res (2013) 0.91
Recognizing familial myeloid leukemia in adults. Ther Adv Hematol (2013) 0.90
Mendelian genetics of human susceptibility to fungal infection. Cold Spring Harb Perspect Med (2014) 0.89
Genetic predisposition syndromes: when should they be considered in the work-up of MDS? Best Pract Res Clin Haematol (2014) 0.89
Learning from other diseases: protection and pathology in chronic fungal infections. Semin Immunopathol (2015) 0.84
MonoMAC versus idiopathic CD4+ lymphocytopenia. Comment to Haematologica. 2011;96(8):1221-5. Haematologica (2012) 0.83
Genetic predispositions to childhood leukemia. Ther Adv Hematol (2013) 0.82
Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells. Blood (2017) 0.82
GATA2 deficiency. Curr Opin Allergy Clin Immunol (2015) 0.82
Host response to Candida albicans bloodstream infection and sepsis. Virulence (2015) 0.82
A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections. Semin Immunopathol (2016) 0.81
Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood. Haematologica (2014) 0.81
Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations. Cancer Med (2015) 0.80
Presence of hypogammaglobulinemia and abnormal antibody responses in GATA2 deficiency. J Allergy Clin Immunol (2014) 0.78
Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers. Clin Infect Dis (2016) 0.78
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood. BMC Pulm Med (2015) 0.78
Primary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestations. J Am Acad Dermatol (2015) 0.77
Rheumatologic manifestations of the "MonoMAC" syndrome. a systematic review. Clin Rheumatol (2015) 0.77
Major histocompatibility complex class II deficiency complicated by Mycobacterium avium complex in a boy of mixed ethnicity. J Clin Immunol (2014) 0.77
Host genetics of invasive Aspergillus and Candida infections. Semin Immunopathol (2014) 0.77
Anemia of Central Origin. Semin Hematol (2015) 0.76
GATA2 regulates dendritic cell differentiation. Blood (2016) 0.76
Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease. J Hepatol (2016) 0.76
Bone Marrow Immunity and Myelodysplasia. Front Oncol (2016) 0.75
Management of uterine bleeding during hematopoietic stem cell transplantation. Obstet Gynecol (2013) 0.75
Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets. Front Immunol (2016) 0.75
First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis. Front Microbiol (2016) 0.75
NK cells and virus-related cancers. Crit Rev Oncog (2014) 0.75
Pulmonary Cryptococcosis in the Immunocompetent Patient-Many Questions, Some Answers. Open Forum Infect Dis (2016) 0.75
Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency. Leukemia (2016) 0.75
Genetic Susceptibility to Fungal Infections: What is in the Genes? Curr Clin Microbiol Rep (2016) 0.75
Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine. Can J Kidney Health Dis (2017) 0.75
[Primary immunodeficiency]. Z Rheumatol (2013) 0.75
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 9.39
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82
Papillomaviruses in the causation of human cancers - a brief historical account. Virology (2009) 5.46
Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med (2002) 5.23
Familial myelodysplasia and acute myeloid leukaemia--a review. Br J Haematol (2008) 3.74
Transcriptional control of granulocyte and monocyte development. Oncogene (2007) 3.49
Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med (1999) 3.36
Myelodysplastic syndromes. Blood (2008) 3.24
Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol (2007) 3.16
Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol (2006) 2.79
The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev (2006) 2.62
Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol (2007) 2.55
Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect (2002) 2.43
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med (2008) 2.29
The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med (1978) 2.29
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol (2008) 2.16
Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med (1994) 2.07
The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol (2008) 2.05
Leukemic reticuloendotheliosis (hairy cell leukemia). Blood (1979) 2.04
Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol (2005) 2.03
Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol (2007) 1.74
Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis (2009) 1.70
Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies. J Leukoc Biol (1987) 1.67
Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med (2000) 1.63
Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest (1997) 1.62
Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsy. Leuk Res (2002) 1.60
Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. Science (1978) 1.53
Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS One (2009) 1.41
Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab Invest (1982) 1.31
Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes. Pathol Biol (Paris) (2006) 1.28
Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity. Immunol Res (2007) 1.28
Dual origin of mouse spleen macrophages. J Exp Med (1984) 1.28
HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J Pediatr (2004) 1.23
A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet (2006) 1.22
HPV innate immunity. Front Biosci (2002) 1.21
Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma (2004) 1.17
A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset. J Allergy Clin Immunol (1990) 1.14
The history of tumor virology. Cancer Res (2008) 1.14
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol (2007) 1.14
Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin Immunol (2000) 1.02
Granulomatous infections complicating hairy cell leukemia. Cancer (1982) 0.99
Clinical manifestations and infectious complications of hairy-cell leukaemia. Best Pract Res Clin Haematol (2003) 0.96
Disseminated Mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Am J Hematol (2003) 0.93
Sibling cases of Mycobacterium avium complex disease associated with hematological disease. J Infect Chemother (2006) 0.93
Strong alpha beta and gamma delta TCR response in a patient with disseminated Mycobacterium avium infection and lack of NK cells and monocytopenia. Immunol Lett (2000) 0.90
Hold on, the monocytes are coming! Immunity (2007) 0.87
The hematopoietic stem cell in myelodysplasia. Stem Cells (2004) 0.85
Hairy Cell Leukemia. Curr Treat Options Oncol (2007) 0.84
Remember mycobacterial disease in hairy cell leukaemia (HCL). J Infect (2001) 0.83
Accumulation of uterine CD16(-) natural killer (NK) cells: friends, foes, or Jekyll-and-Hyde relationship for the conceptus? Immunol Invest (2008) 0.81
Pulmonary alveolar proteinosis in pediatric leukemia. Pediatr Blood Cancer (2008) 0.80
Generalized monocyte deficiency in leukaemic reticuloendotheliosis. Scand J Haematol (1982) 0.80
Pulmonary alveolar proteinosis and disseminated Mycobacterium avium infection. Respir Med (1996) 0.80
A patient without monocytes who had pulmonary renal syndrome. Am J Kidney Dis (2004) 0.80
GM-CSF and proteinosis. Thorax (2003) 0.80
Disseminated Mycobacterium avium intracellulare infection without predisposing conditions. Lancet (1992) 0.79
Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects. Cancer Genet Cytogenet (2004) 0.79
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature (2008) 38.13
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science (2002) 19.77
BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods (2009) 18.41
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12
VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics (2009) 16.04
Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07
Mapping copy number variation by population-scale genome sequencing. Nature (2011) 12.55
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol (2011) 9.19
STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99
Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature (2008) 8.17
Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis (2006) 8.17
Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature (2012) 8.03
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med (2007) 7.75
A diversity profile of the human skin microbiota. Genome Res (2008) 7.65
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet (2012) 7.61
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood (2010) 7.25
Clonal architecture of secondary acute myeloid leukemia. N Engl J Med (2012) 6.71
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med (2006) 6.17
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood (2010) 5.95
Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med (2012) 5.87
SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics (2011) 5.62
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med (2014) 5.37
Phanerozoic trends in the global diversity of marine invertebrates. Science (2008) 5.36
CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods (2011) 5.34
Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med (2008) 5.34
Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol (2005) 5.18
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell (2002) 5.10
A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature (2012) 5.02
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med (2013) 4.96
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
MuSiC: identifying mutational significance in cancer genomes. Genome Res (2012) 4.73
Activating HER2 mutations in HER2 gene amplification negative breast cancer. Cancer Discov (2012) 4.72
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med (2009) 4.52
Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med (2003) 4.46
Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A (2008) 4.38
Landscape of somatic retrotransposition in human cancers. Science (2012) 4.37
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med (2008) 4.33
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature (2012) 4.33
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood (2011) 4.21
Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis (2010) 4.19
Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis (2008) 4.16
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA (2011) 4.11
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant (2006) 4.09
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet (2011) 4.02